Oncopeptides AB buy melinda
Start price
26.09.19
/
50%
€11.20
Target price
30.10.19
-
Performance (%)
-9.11%
End price
30.10.19
€10.18
Summary
This prediction ended on 30.10.19 with a price of €10.18. With a performance of -9.11%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Oncopeptides AB | -0.792% | -0.792% | -74.605% | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
According to melinda what are the pros and cons of Oncopeptides AB for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Oncopeptides AB diskutieren
Buy Oncopeptides AB
Stopped prediction by melinda for Oncopeptides AB
Oncopeptides AB
Start price
Target price
Perf. (%)
€1.02
02.12.21
02.12.21
€1.50
02.12.22
02.12.22
56.67%
03.12.22
03.12.22
Could be worthwhile Investment >10% per year
Oncopeptides AB
Start price
Target price
Perf. (%)
€15.93
20.11.20
20.11.20
€18.00
20.11.21
20.11.21
-91.88%
21.11.21
21.11.21
Could be worthwhile Investment >10% per year